位置:首页 > 蛋白库 > MTU1_HUMAN
MTU1_HUMAN
ID   MTU1_HUMAN              Reviewed;         421 AA.
AC   O75648; A8K3U7; Q05C99; Q5W9C8; Q66K31; Q6ICC3; Q9NWC1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 2.
DT   03-AUG-2022, entry version 159.
DE   RecName: Full=Mitochondrial tRNA-specific 2-thiouridylase 1;
DE            EC=2.8.1.14 {ECO:0000250|UniProtKB:Q12093};
DE   AltName: Full=MTO2 homolog;
GN   Name=TRMU; Synonyms=MTU1, TRMT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=16513084; DOI=10.1016/j.bbrc.2006.02.078;
RA   Yan Q., Bykhovskaya Y., Li R., Mengesha E., Shohat M., Estivill X.,
RA   Fischel-Ghodsian N., Guan M.-X.;
RT   "Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-
RT   methyltransferase is a putative nuclear modifier gene for the phenotypic
RT   expression of the deafness-associated 12S rRNA mutations.";
RL   Biochem. Biophys. Res. Commun. 342:1130-1136(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ASP-16.
RX   PubMed=15509579; DOI=10.1074/jbc.m409306200;
RA   Umeda N., Suzuki T., Yukawa M., Ohya Y., Shindo H., Watanabe K., Suzuki T.;
RT   "Mitochondria-specific RNA-modifying enzymes responsible for the
RT   biosynthesis of the wobble base in mitochondrial tRNAs. Implications for
RT   the molecular pathogenesis of human mitochondrial diseases.";
RL   J. Biol. Chem. 280:1613-1624(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Embryo, and Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15944150; DOI=10.1074/jbc.m504247200;
RA   Yan Q., Li X., Faye G., Guan M.-X.;
RT   "Mutations in MTO2 related to tRNA modification impair mitochondrial gene
RT   expression and protein synthesis in the presence of a paromomycin
RT   resistance mutation in mitochondrial 15 S rRNA.";
RL   J. Biol. Chem. 280:29151-29157(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INVOLVEMENT IN DFNI, VARIANT SER-10, CHARACTERIZATION OF VARIANT SER-10,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16826519; DOI=10.1086/506389;
RA   Guan M.-X., Yan Q., Li X., Bykhovskaya Y., Gallo-Teran J., Hajek P.,
RA   Umeda N., Zhao H., Garrido G., Mengesha E., Suzuki T., del Castillo I.,
RA   Peters J.L., Li R., Qian Y., Wang X., Ballana E., Shohat M., Lu J.,
RA   Estivill X., Watanabe K., Fischel-Ghodsian N.;
RT   "Mutation in TRMU related to transfer RNA modification modulates the
RT   phenotypic expression of the deafness-associated mitochondrial 12S
RT   ribosomal RNA mutations.";
RL   Am. J. Hum. Genet. 79:291-302(2006).
RN   [11]
RP   VARIANTS LFIT HIS-77 AND ASP-272, AND VARIANTS SER-10; SER-14 AND MET-279.
RX   PubMed=19732863; DOI=10.1016/j.ajhg.2009.08.004;
RA   Zeharia A., Shaag A., Pappo O., Mager-Heckel A.-M., Saada A., Beinat M.,
RA   Karicheva O., Mandel H., Ofek N., Segel R., Marom D., Roetig A.,
RA   Tarassov I., Elpeleg O.;
RT   "Acute infantile liver failure due to mutations in the TRMU gene.";
RL   Am. J. Hum. Genet. 85:401-407(2009).
RN   [12]
RP   ERRATUM OF PUBMED:19732863.
RA   Zeharia A., Shaag A., Pappo O., Mager-Heckel A.-M., Saada A., Beinat M.,
RA   Karicheva O., Mandel H., Ofek N., Segel R., Marom D., Roetig A.,
RA   Tarassov I., Elpeleg O.;
RL   Am. J. Hum. Genet. 86:295-295(2010).
RN   [13]
RP   CHARACTERIZATION OF VARIANT SER-10.
RX   PubMed=28049726; DOI=10.1074/jbc.m116.749374;
RA   Meng F., Cang X., Peng Y., Li R., Zhang Z., Li F., Fan Q., Guan A.S.,
RA   Fischel-Ghosian N., Zhao X., Guan M.X.;
RT   "Biochemical evidence for a nuclear modifier allele (A10S) in TRMU
RT   (Methylaminomethyl-2-thiouridylate-methyltransferase) related to
RT   mitochondrial tRNA modification in the phenotypic manifestation of
RT   deafness-associated 12S rRNA mutation.";
RL   J. Biol. Chem. 292:2881-2892(2017).
CC   -!- FUNCTION: Catalyzes the 2-thiolation of uridine at the wobble position
CC       (U34) of mitochondrial tRNA(Lys), tRNA(Glu) and tRNA(Gln). Required for
CC       the formation of 5-taurinomethyl-2-thiouridine (tm5s2U) of
CC       mitochondrial tRNA(Lys), tRNA(Glu), and tRNA(Gln) at the wobble
CC       position. ATP is required to activate the C2 atom of the wobble base.
CC       {ECO:0000269|PubMed:15509579, ECO:0000269|PubMed:15944150,
CC       ECO:0000269|PubMed:16826519}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-taurinomethyluridine(34) in tRNA + AH2 + ATP + S-sulfanyl-L-
CC         cysteinyl-[protein] = 5-taurinomethyl-2-thiouridine(34) in tRNA + A +
CC         AMP + diphosphate + H(+) + L-cysteinyl-[protein];
CC         Xref=Rhea:RHEA:47040, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:11726,
CC         Rhea:RHEA-COMP:11732, Rhea:RHEA-COMP:11733, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17499, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:61963,
CC         ChEBI:CHEBI:87171, ChEBI:CHEBI:87172, ChEBI:CHEBI:456215;
CC         EC=2.8.1.14; Evidence={ECO:0000250|UniProtKB:Q12093};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:15509579,
CC       ECO:0000269|PubMed:15944150, ECO:0000269|PubMed:16513084,
CC       ECO:0000269|PubMed:16826519}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O75648-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75648-2; Sequence=VSP_035395;
CC       Name=3;
CC         IsoId=O75648-3; Sequence=VSP_035391, VSP_035392, VSP_035395;
CC       Name=4;
CC         IsoId=O75648-4; Sequence=VSP_035391, VSP_035392;
CC       Name=5;
CC         IsoId=O75648-5; Sequence=VSP_035393, VSP_035394;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Abundantly expressed in tissues with
CC       high metabolic rates including heart, liver, kidney, and brain.
CC       {ECO:0000269|PubMed:16513084}.
CC   -!- DISEASE: Deafness, aminoglycoside-induced (DFNI) [MIM:580000]: A form
CC       of sensorineural deafness characterized by moderate-to-profound hearing
CC       loss and mitochondrial inheritance. It is induced by exposure to
CC       aminoglycosides. {ECO:0000269|PubMed:16826519}. Note=The gene
CC       represented in this entry acts as a disease modifier. DFNI is caused by
CC       mutations in mitochondrial rRNA genes, including homoplasmic A1555G and
CC       C1494T mutations in the highly conserved decoding site of the
CC       mitochondrial 12S rRNA. Mutated TRMU modulates the phenotypic
CC       manifestation of these mutations. {ECO:0000269|PubMed:16826519}.
CC   -!- DISEASE: Liver failure, infantile, transient (LFIT) [MIM:613070]: A
CC       transient disorder of hepatic function characterized by elevated liver
CC       enzymes, jaundice, vomiting, coagulopathy, hyperbilirubinemia,
CC       increased serum lactate. Patients who survive the initial acute episode
CC       can recover, show normal development and have no recurrence.
CC       {ECO:0000269|PubMed:19732863}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: During the reaction, ATP is used to activate the C2 atom
CC       of U34 by adenylation. After this, the persulfide sulfur on the
CC       catalytic cysteine is transferred to the C2 atom of the wobble base
CC       (U34) of mitochondrial tRNA(Lys), tRNA(Glu) and tRNA(Gln). The reaction
CC       probably involves hydrogen sulfide that is generated from the
CC       persulfide intermediate and that acts as nucleophile towards the
CC       activated C2 atom on U34. Subsequently, a transient disulfide bond is
CC       formed between the two active site cysteine residues (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the MnmA/TRMU family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to be a 5-methylaminomethyl-2-
CC       methyltransferase involved in tRNA modification.
CC       {ECO:0000305|PubMed:16513084}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY062123; AAL38183.1; -; mRNA.
DR   EMBL; AF448221; AAL35970.1; -; Genomic_DNA.
DR   EMBL; AB178028; BAD66875.1; -; mRNA.
DR   EMBL; CR456445; CAG30331.1; -; mRNA.
DR   EMBL; AK001002; BAA91462.1; -; mRNA.
DR   EMBL; AK290712; BAF83401.1; -; mRNA.
DR   EMBL; AL031588; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471138; EAW73422.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73426.1; -; Genomic_DNA.
DR   EMBL; BC027991; AAH27991.1; -; mRNA.
DR   EMBL; BC080631; AAH80631.1; -; mRNA.
DR   CCDS; CCDS14075.1; -. [O75648-1]
DR   CCDS; CCDS63510.1; -. [O75648-2]
DR   RefSeq; NP_001269712.1; NM_001282783.1.
DR   RefSeq; NP_001269713.1; NM_001282784.1.
DR   RefSeq; NP_001269714.1; NM_001282785.1. [O75648-2]
DR   RefSeq; NP_060476.2; NM_018006.4. [O75648-1]
DR   AlphaFoldDB; O75648; -.
DR   SMR; O75648; -.
DR   BioGRID; 120814; 103.
DR   IntAct; O75648; 8.
DR   STRING; 9606.ENSP00000290846; -.
DR   iPTMnet; O75648; -.
DR   PhosphoSitePlus; O75648; -.
DR   BioMuta; TRMU; -.
DR   EPD; O75648; -.
DR   jPOST; O75648; -.
DR   MassIVE; O75648; -.
DR   MaxQB; O75648; -.
DR   PaxDb; O75648; -.
DR   PeptideAtlas; O75648; -.
DR   PRIDE; O75648; -.
DR   ProteomicsDB; 50138; -. [O75648-1]
DR   ProteomicsDB; 50139; -. [O75648-2]
DR   ProteomicsDB; 50140; -. [O75648-3]
DR   ProteomicsDB; 50141; -. [O75648-4]
DR   ProteomicsDB; 50142; -. [O75648-5]
DR   Antibodypedia; 28061; 187 antibodies from 18 providers.
DR   DNASU; 55687; -.
DR   Ensembl; ENST00000381019.3; ENSP00000370407.3; ENSG00000100416.15. [O75648-2]
DR   Ensembl; ENST00000457572.5; ENSP00000407700.1; ENSG00000100416.15. [O75648-5]
DR   Ensembl; ENST00000645190.1; ENSP00000496496.1; ENSG00000100416.15. [O75648-1]
DR   GeneID; 55687; -.
DR   KEGG; hsa:55687; -.
DR   MANE-Select; ENST00000645190.1; ENSP00000496496.1; NM_018006.5; NP_060476.2.
DR   UCSC; uc003bhp.4; human. [O75648-1]
DR   CTD; 55687; -.
DR   DisGeNET; 55687; -.
DR   GeneCards; TRMU; -.
DR   HGNC; HGNC:25481; TRMU.
DR   HPA; ENSG00000100416; Low tissue specificity.
DR   MalaCards; TRMU; -.
DR   MIM; 580000; phenotype.
DR   MIM; 610230; gene.
DR   MIM; 613070; phenotype.
DR   neXtProt; NX_O75648; -.
DR   OpenTargets; ENSG00000100416; -.
DR   Orphanet; 217371; Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins.
DR   Orphanet; 254864; Mitochondrial myopathy with reversible cytochrome C oxidase deficiency.
DR   Orphanet; 90641; Mitochondrial non-syndromic sensorineural deafness.
DR   PharmGKB; PA142670701; -.
DR   VEuPathDB; HostDB:ENSG00000100416; -.
DR   eggNOG; KOG2805; Eukaryota.
DR   GeneTree; ENSGT00390000014323; -.
DR   HOGENOM; CLU_035188_1_1_1; -.
DR   InParanoid; O75648; -.
DR   OMA; AVCTGHY; -.
DR   OrthoDB; 697006at2759; -.
DR   PhylomeDB; O75648; -.
DR   TreeFam; TF105611; -.
DR   BioCyc; MetaCyc:ENSG00000100416-MON; -.
DR   BRENDA; 2.1.1.61; 2681.
DR   PathwayCommons; O75648; -.
DR   Reactome; R-HSA-6787450; tRNA modification in the mitochondrion.
DR   SignaLink; O75648; -.
DR   BioGRID-ORCS; 55687; 24 hits in 1081 CRISPR screens.
DR   ChiTaRS; TRMU; human.
DR   GeneWiki; TRMU; -.
DR   GenomeRNAi; 55687; -.
DR   Pharos; O75648; Tbio.
DR   PRO; PR:O75648; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; O75648; protein.
DR   Bgee; ENSG00000100416; Expressed in apex of heart and 176 other tissues.
DR   ExpressionAtlas; O75648; baseline and differential.
DR   Genevisible; O75648; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0061708; F:tRNA-5-taurinomethyluridine 2-sulfurtransferase; IEA:RHEA.
DR   GO; GO:0002143; P:tRNA wobble position uridine thiolation; IBA:GO_Central.
DR   CDD; cd01998; tRNA_Me_trans; 1.
DR   Gene3D; 2.30.30.280; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_00144; tRNA_thiouridyl_MnmA; 1.
DR   InterPro; IPR023382; Adenine_a_hdrlase_dom.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR004506; tRNA-specific_2-thiouridylase.
DR   TIGRFAMs; TIGR00420; trmU; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Deafness; Disease variant;
KW   Disulfide bond; Mitochondrion; Non-syndromic deafness; Nucleotide-binding;
KW   Reference proteome; RNA-binding; Transferase; tRNA processing;
KW   tRNA-binding.
FT   CHAIN           1..421
FT                   /note="Mitochondrial tRNA-specific 2-thiouridylase 1"
FT                   /id="PRO_0000121708"
FT   REGION          96..98
FT                   /note="Interaction with target base in tRNA"
FT                   /evidence="ECO:0000250"
FT   REGION          171..173
FT                   /note="Interaction with tRNA"
FT                   /evidence="ECO:0000250"
FT   REGION          334..335
FT                   /note="Interaction with tRNA"
FT                   /evidence="ECO:0000250"
FT   REGION          395..421
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        101
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        222
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         10..17
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         36
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         126
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   SITE            127
FT                   /note="Interaction with tRNA"
FT                   /evidence="ECO:0000250"
FT   SITE            267
FT                   /note="Interaction with tRNA"
FT                   /evidence="ECO:0000250"
FT   SITE            367
FT                   /note="Interaction with tRNA"
FT                   /evidence="ECO:0000250"
FT   DISULFID        101..222
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..154
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_035391"
FT   VAR_SEQ         155..179
FT                   /note="FEVRNAVKLLQAADSFKDQTFFLSQ -> MKKSLSRSTLRSPKGFSEIGLKL
FT                   EM (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_035392"
FT   VAR_SEQ         161..166
FT                   /note="VKLLQA -> RFPRMP (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_035393"
FT   VAR_SEQ         167..421
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_035394"
FT   VAR_SEQ         341..421
FT                   /note="PCVLTLNQDGTVWVTAVQAVRALATGQFAVFYKGDECLGSGKILRLGPSAYT
FT                   LQKGQRRAGMATESPSDSPEDGPGLSPLL -> CCVLQGGRVPGQREDPAAGAVCLHAP
FT                   EGPAQSWDGH (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15461802,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_035395"
FT   VARIANT         10
FT                   /note="A -> S (acts as a disease modifier in patients with
FT                   aminoglycoside-induced deafness and a mutation in
FT                   mitochondrial 12S rRNA; affects tRNA processing by
FT                   decreasing thiolation and increasing aminoacylation of
FT                   tRNAs; the mutant has lower thermal stability than wild-
FT                   type; does not affect import in the mitochondria;
FT                   dbSNP:rs11090865)"
FT                   /evidence="ECO:0000269|PubMed:16826519,
FT                   ECO:0000269|PubMed:19732863, ECO:0000269|PubMed:28049726"
FT                   /id="VAR_027268"
FT   VARIANT         14
FT                   /note="G -> S (in dbSNP:rs751248771)"
FT                   /evidence="ECO:0000269|PubMed:19732863"
FT                   /id="VAR_063428"
FT   VARIANT         25
FT                   /note="R -> S (in dbSNP:rs2272938)"
FT                   /id="VAR_046380"
FT   VARIANT         77
FT                   /note="Y -> H (in LFIT; dbSNP:rs118203990)"
FT                   /evidence="ECO:0000269|PubMed:19732863"
FT                   /id="VAR_063429"
FT   VARIANT         148
FT                   /note="E -> K (in dbSNP:rs34012206)"
FT                   /id="VAR_046381"
FT   VARIANT         272
FT                   /note="G -> D (in LFIT; dbSNP:rs118203991)"
FT                   /evidence="ECO:0000269|PubMed:19732863"
FT                   /id="VAR_063430"
FT   VARIANT         279
FT                   /note="V -> M (in dbSNP:rs387907022)"
FT                   /evidence="ECO:0000269|PubMed:19732863"
FT                   /id="VAR_063431"
FT   VARIANT         398
FT                   /note="R -> C (in dbSNP:rs34152016)"
FT                   /id="VAR_046382"
FT   MUTAGEN         16
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:15509579"
FT   CONFLICT        139
FT                   /note="F -> L (in Ref. 4; BAA91462)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        O75648-3:14
FT                   /note="K -> N (in Ref. 7; AAH80631)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   421 AA;  47745 MW;  F06A57DED79BBE84 CRC64;
     MQALRHVVCA LSGGVDSAVA ALLLRRRGYQ VTGVFMKNWD SLDEHGVCTA DKDCEDAYRV
     CQILDIPFHQ VSYVKEYWND VFSDFLNEYE KGRTPNPDIV CNKHIKFSCF FHYAVDNLGA
     DAIATGHYAR TSLEDEEVFE QKHVKKPEGL FRNRFEVRNA VKLLQAADSF KDQTFFLSQV
     SQDALRRTIF PLGGLTKEFV KKIAAENRLH HVLQKKESMG MCFIGKRNFE HFLLQYLQPR
     PGHFISIEDN KVLGTHKGWF LYTLGQRANI GGLREPWYVV EKDSVKGDVF VAPRTDHPAL
     YRDLLRTSRV HWIAEEPPAA LVRDKMMECH FRFRHQMALV PCVLTLNQDG TVWVTAVQAV
     RALATGQFAV FYKGDECLGS GKILRLGPSA YTLQKGQRRA GMATESPSDS PEDGPGLSPL
     L
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024